Author name: Leonardo Arias

The technology giant is working with Hackensack Meridian Health on multiple agents, including a tool that can summarize patients’ medical records for providers.

Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall Street consensus expectations.

Analysts expect that DePuy Synthes could become a stronger competitor as a standalone company.

The deal would offer UPMC an entrance into the Ohio market.

The clinical assistant will be able to record nurses’ interactions with patients and help document their care. The tool will be generally available in the U.S. starting in December.

While some companies are using regional supply chains or leaning on tariff exemptions by maximizing compliance, others are frozen in place.

In this episode presented by PII, BioSpace’s head of insights discusses decentralized clinical studies and how connected technology can improve patient compliance with guests Oliver Eden and Travis Webb.

Veradermics joins fellow hair regrowth specialist Pelage Pharmaceuticals, which on Wednesday raised $120 million for its own therapy.

An unnamed source clarified that Sandra Retzky has not been fired from the FDA, but it remains unclear where she was reassigned.

The partners have yet to disclose what their priority indications are, though EVOQ’s NanoDisc technology aims to enable the development of potentially curative treatments for autoimmune conditions such as celiac disease and type 1 diabetes.